In the present analyses of data from the EPIC–Heidelberg, E-Selectin showed a non-linear association with T2D risk, while ICAM3 showed an inverse association with T2D over a median 16 year follow-up period. Here, ICAM3 is linked to type 2 diabetes mellitus.